laitimes

The number of shareholders of Walvax Biotech decreased by 983, with an average shareholding of 198,200 yuan

author:Oriental Fortune Network
The number of shareholders of Walvax Biotech decreased by 983, with an average shareholding of 198,200 yuan

Walvax disclosed in its first quarter report on April 25, 2024 that the number of shareholders of the company as of March 31, 2024 was 121,700, a decrease of 983 or 0.80% from the previous period (February 29, 2024).

The number of shareholders of Walvax Biotech is higher than the industry average. According to Choice data, as of March 31, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 34,200. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 29.25%.

Distribution of the number of shareholders in the pharmaceutical and biological industry

The number of shareholders of Walvax Biotech decreased by 983, with an average shareholding of 198,200 yuan

Number of shareholders and share price

Since June 30, 2023, the number of shareholders of the company has decreased, with a decrease of 5.85%. From June 30, 2023 to March 31, 2024, the stock price decreased by 41.85%.

Number of shareholders and share price

The number of shareholders of Walvax Biotech decreased by 983, with an average shareholding of 198,200 yuan

Number of shareholders and share capital

As of March 31, 2024, the company's latest total share capital is 1.607 billion shares, of which the outstanding share capital is 1.568 billion shares. The average number of outstanding shares held by households increased from 12,800 shares in the previous period to 12,900 shares, and the average market value of households was 198,200 yuan.

The average amount of shares held by each household

The number of shareholders of Walvax Biotech decreased by 983, with an average shareholding of 198,200 yuan

The average market value of Watson Biotech is lower than the industry average. According to Choice data, as of March 31, 2024, the average market value of A-share listed companies in the pharmaceutical and biotechnology industry was 396,100 yuan. Among them, 25.73% of the company's households hold a circulating stock market value in the range of 130,000~270,000, and Walvax Biotech is also in the range.

Distribution of per capita circulating market value of the pharmaceutical and biological industry

The number of shareholders of Walvax Biotech decreased by 983, with an average shareholding of 198,200 yuan

SZSE shareholdings

On March 31, 2024, the number of shares held by Shenzhen Stock Connect was 49,683,600 shares, accounting for 3.09% of the outstanding share capital, a decrease of 3.34% from 51,398,500 shares in the previous period (February 29, 2024).

SZSE shareholding chart

The number of shareholders of Walvax Biotech decreased by 983, with an average shareholding of 198,200 yuan

Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.